An improved procedure for quantitation of platelet factor 4

Area of Science:

• Biochemistry
• Hematology
• Clinical Chemistry

Background:

• Platelet factor 4 is a protein released from platelets.
• It possesses heparin-neutralizing activity, impacting coagulation.
• Accurate quantification of platelet factor 4 is crucial for understanding hemostasis and thrombosis.

Purpose of the Study:

• To develop and validate a quantitative assay for platelet factor 4 (PF4) activity.
• To utilize the heparin-neutralizing property of PF4 for assay development.
• To enhance the sensitivity and precision of PF4 measurement.

Main Methods:

• A heparin dose-response curve was generated using commercial plasma and varying heparin concentrations to determine thrombin time.
• A specific heparin concentration yielding a reproducible, maximal thrombin time was selected.
• Thrombin times of heparinized plasma were measured before and after adding test material containing PF4.
• PF4 activity was determined by calculating the difference in heparin concentrations corresponding to the measured thrombin times using the calibration curve.

Main Results:

• The assay demonstrated that platelet factor 4 activity directly correlates with its ability to neutralize heparin.
• Using lyophilized plasma as a substrate allowed for higher heparin concentrations, improving assay sensitivity.
• The method provides a precise and reproducible measurement of PF4 heparin-neutralizing activity.

Conclusions:

• The developed assay accurately quantifies platelet factor 4 activity based on its heparin-neutralizing capacity.
• The assay offers improved sensitivity and precision, particularly when using lyophilized plasma.
• This method provides a valuable tool for clinical and research settings investigating platelet function and coagulation disorders.